This site is intended for health professionals only
Newsletter
Hospital Healthcare Europe
Login
Twitter
Linkedin
Facebook
Select Language
English
French
German
Italian
Spanish
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
News
Views
Reviews & Research
Clinical
Cardiovascular
Dermatology
Gastroenterology
Medicines safety
Mental health
Neurology
Oncology
Paediatrics
Respiratory
Rheumatology
Sponsored
Events
Home
>
Dermatology
Dermatology
US FDA approval of Xolair® for chronic idiopathic urticaria
New phase III psoriasis data show rapid, significant skin clearance with secukinumab
Biologics in moderate-to-severe plaque psoriasis
Positive opinion from CHMP for Xolair®
Biosimilars in dermatology
Documentary featuring psoriasis patients wins prestigious award
Call for action to improve standards of care for people living with psoriasis in Europe
Psoriasis care falling short of recommended clinical guidelines
Psoriasis patients should be screened for CVD
Oral apremilast phase III ESTEEM 1 study
Pivotal Novartis Phase III psoriasis results at EADV
Novartis Phase III results from specialty dermatology portfolio
« Previous
1
…
10
11
12
13
14
…
21
Next »
Most read
1
Transcranial magnetic stimulation brain connectivity changes in major depression visible on MRI scan
by Rod Tucker
2
Oral vitamin A could become an alternative to isotretinoin for acne
by Rod Tucker
3
Amino acids supplement reduces muscle wasting and improves gut function in critically ill
by Rod Tucker
4
Less than two-thirds of patients alive 10 years after out-of-hospital cardiac arrest
by Rod Tucker
5
Launch of the new Hospital Pharmacy Europe Mobile App
by aporter2
Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
x
Search for: